Radiologix losses widen

Article

For the fourth quarter 2003, imaging services provider Radiologix reported service fee revenue of $66 million versus $64 million in the same period of the previous year, a 3.1% increase. But the company noted a net loss of $3 million for the quarter

For the fourth quarter 2003, imaging services provider Radiologix reported service fee revenue of $66 million versus $64 million in the same period of the previous year, a 3.1% increase. But the company noted a net loss of $3 million for the quarter compared with a net loss of $1.6 million for the fourth quarter 2002 and a loss from continuing operations of $1.3 million compared with a continuing operations loss of $585,000 in the fourth quarter of 2002. In fiscal year 2003, service-fee revenue fell 5.6% to $257 million from $272.2 million the previous year. The company incurred a net loss of $8 million for fiscal year 2003 compared with net income of $10.8 million for the year before. For fiscal year 2003, loss from continuing operations was $1.1 million, compared with income from continuing operations of $11.5 million for fiscal 2002.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.